More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-04-17-13-21-04-932-69e233c07c52c60ac8ec8e33.jpg)
/Passle/59994aefb00e801a0c1447be/MediaLibrary/Images/2026-04-07-08-00-15-424-69d4b98fdf20114810cf62f5.jpeg)
/Passle/59994aefb00e801a0c1447be/MediaLibrary/Images/5d95c81b8cb6230bac629b4d/2022-06-10-11-05-56-063-62a32594f636ea1acc4cd7c7.jpg)